Cited by 101Posttraumatic Stress Disorder ResearchTraumatic Brain Injury ResearchChild Abuse and Trauma

Multi-omic biomarker identification and validation for diagnosing warzone-related post-traumatic stress disorder

Open access
The PTSD Systems Biology Consortium, Dean, Kelsey R., Hammamieh, Rasha, Mellon, Synthia H., Abu-Amara, Duna, Flory, Janine D., Guffanti, Guia, Wang, Kai +32 more·2020·Molecular Psychiatry

Abstract

Post-traumatic stress disorder (PTSD) impacts many veterans and active duty soldiers, but diagnosis can be problematic due to biases in self-disclosure of symptoms, stigma within military populations, and limitations identifying those at risk. Prior studies suggest that PTSD may be a systemic illness, affecting not just the brain, but the entire body. Therefore, disease signals likely span multiple biological domains, including genes, proteins, cells, tissues, and organism-level physiological changes. Identification of these signals could aid in diagnostics, treatment decision-making, and risk evaluation. In the search for PTSD diagnostic biomarkers, we ascertained over one million molecular, cellular, physiological, and clinical features from three cohorts of male veterans. In a discovery cohort of 83 warzone-related PTSD cases and 82 warzone-exposed controls, we identified a set of 343 candidate biomarkers. These candidate biomarkers were selected from an integrated approach using (1) data-driven methods, including Support Vector Machine with Recursive Feature Elimination and other standard or published methodologies, and (2) hypothesis-driven approaches, using previous genetic studies for polygenic risk, or other PTSD-related literature. After reassessment of ~30% of these participants, we refined this set of markers from 343 to 28, based on their performance and ability to track changes in phenotype over time. The final diagnostic panel of 28 features was validated in an independent cohort (26 cases, 26 controls) with good performance (AUC = 0.80, 81% accuracy, 85% sensitivity, and 77% specificity). The identification and validation of this diverse diagnostic panel represents a powerful and novel approach to improve accuracy and reduce bias in diagnosing combat-related PTSD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-019-0496-z

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Efficient insulin action is essential for inhibition of proteolysis.

    “Efficient insulin action is essential for inhibition of proteolysis (17); therefore, insulin resistance would enhance the proteolytic effect adding to amino acid pool in the plasma.”

    From Mechanistic inferences on metabolic dysfunction in posttraumatic stress disorder from an integrated model and multiomic analysis: role of glucocorticoid receptor sensitivity (2019) · cites this paper as [17]

    The Results section lists insulin as a PTSD biomarker and notes increased insulin resistance in veterans with PTSD, but does not discuss insulin’s effect on proteolysis. Searches for insulin action, proteolysis, and plasma amino acids found no passage in our copy addressing the attributed claim; page numbers were unavailable. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 52

  1. [2]Kang HK Natelson BH Mahan CM Lee KY Murphy FM Post-traumatic stress disorder and chronic fatigue syndrome-like illness among gulf war veterans: a population-based survey of 30,000 veterans Am J Epidemiol 2003 157 141 8 12522021
  2. [3]Seal KH Bertenthal D Miner CR Sen S Marmar C Bringing the war back home Arch Intern Med 2007 167 476 82 17353495
  3. [4]Marmar CR Course of posttraumatic stress disorder 40 years after the Vietnam war JAMA Psychiatry 2015 72 875 26201054
  4. [6]Mellon SH Gautam A Hammamieh R Jett M Wolkowitz OM Metabolism, metabolomics, and inflammation in posttraumatic stress disorder Biol Psychiatry 2018 83 866 75 29628193
  5. [7]Shalev A Liberzon I Marmar C Post-traumatic stress disorder N Engl J Med 2017 376 2459 69 28636846
  6. [10]Breen MS PTSD blood transcriptome mega-analysis: shared inflammatory pathways across biological sex and modes of trauma Neuropsychopharmacology 2018 43 469 81 28925389 PMC5770765
  7. [11]Le-Niculescu H, et al. Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs. Mol Psychiatry. 2019. 10.1038/s41380-019-0370-z. PMC7192849 30862937 · DOI
  8. [12]Zhang Z Molecular subtyping of serous ovarian cancer based on multi-omics data Sci Rep 2016 6 26001 27184229 PMC4868982
  9. [13]The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 2008 455 1061 8 18772890 PMC2671642
  10. [14]The Cancer Genome Atlas Research Network. Comprehensive molecular portraits of human breast tumours Nature 2012 490 61 70 23000897 PMC3465532
  11. [15]Redón J Monleón D Combining -omics in the search for mechanisms in complex trait diseases J Hypertens 2015 33 698 9 25915872
  12. [16]Benson M Clinical implications of omics and systems medicine: focus on predictive and individualized treatment J Intern Med 2016 279 229 40 26891944
  13. [17]Raghavachari N, Gucek M. Pharmacogenomics, pharmacoproteomics, and pharmacometabolomics and personalized medicine: an overview. In: Barh D, Dhawan D, Ganguly NK, editors. Omics for personalized medicine. India: Springer; 2013. p. 3–18.
  14. [18]Thakur GS Systems biology approach to understanding post-traumatic stress disorder Mol Biosyst 2015 11 980 93 25627823
  15. [19]Mitra K Carvunis A-R Ramesh SK Ideker T Integrative approaches for finding modular structure in biological networks Nat Rev Genet 2013 14 719 24045689 PMC3940161
  16. [20]Rantalainen M. Combining metabonomics and other -omics data. Methods Mol Biol. 2015; 147–59. 10.1007/978-1-4939-2377-9_12. 25677153 · DOI
  17. [21]First M, Gibbon M, Spitzer R, Williams J, Benjamin L. Structured clinical interview for DSM-IV axis II personality disorders, (SCID-II). American Psychiatric Press, Inc.; 1997.
  18. [23]Wu X sRNAnalyzer—a flexible and customizable small RNA sequencing data analysis pipeline Nucl Acids Res 2017 45 12140 51 29069500 PMC5716150
  19. [25]Kurvers RHJM Krause J Argenziano G Zalaudek I Wolf M Detection accuracy of collective intelligence assessments for skin cancer diagnosis JAMA Dermatol 2015 151 1346 26501400
  20. [26]Ow GS Kuznetsov VA Big genomics and clinical data analytics strategies for precision cancer prognosis Sci Rep 2016 6 1 13 27819294 PMC5098145
  21. [27]Yang R, Daigle BJ, Jr. Petzold LR, Doyle FJ, III. Core module biomarker identification with network exploration for breast cancer metastasis. BMC Bioinformatics. 2012;13:12. PMC3349569 22257533
  22. [28]Chatterjee N Shi J García-Closas M Developing and evaluating polygenic risk prediction models for stratified disease prevention Nat Rev Genet 2016 17 392 406 27140283 PMC6021129
  23. [29]Duncan LE Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability Mol Psychiatry 2018 23 666 73 28439101 PMC5696105
  24. [30]Peykov S Identification and functional characterization of rare SHANK2 variants in schizophrenia Mol Psychiatry 2015 20 1489 98 25560758 PMC4653611
  25. [31]Luykx JJ Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid Mol Psychiatry 2014 19 228 34 23319000
  26. [32]Zhang L, et al. Mitochondria-focused gene expression profile reveals common pathways and CPT1B dysregulation in both rodent stress model and human subjects with PTSD. Transl Psychiatry. 2015;5:e580. PMC4490278 26080315
  27. [33]Ali-Sisto T Global arginine bioavailability ratio is decreased in patients with major depressive disorder J Affect Disord 2018 229 145 51 29310063
  28. [34]Bersani FS Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation Brain Behav Immun 2016 52 153 60 26515034
  29. [35]Zierer J Metabolomics profiling reveals novel markers for leukocyte telomere length Aging (Albany NY) 2016 8 77 86 26797767 PMC4761715
  30. [36]Shalev AY A prospective study of heart rate response following trauma and the subsequent development of posttraumatic stress disorder Arch Gen Psychiat 1998 55 553 9633675
  31. [37]Ghai V Genome-wide profiling of urinary extracellular vesicle microRNAs associated with diabetic nephropathy in type 1 diabetes Kidney Int Rep 2018 3 555 72 29854963 PMC5976846
  32. [38]Ma X, Lu C, Lv C, Wu C, Wang Q. The expression of miR-192 and its significance in diabetic nephropathy patients with different urine albumin creatinine ratio. J Diabetes Res. 2016:1–6. PMC4736386 26881255
  33. [39]de Gonzalo-Calvo D Circulating inflammatory miRNA signature in response to different doses of aerobic exercise J Appl Physiol 2015 119 124 34 25997943
  34. [42]Jensen CF Behavioral and plasma cortisol responses to sodium lactate infusion in posttraumatic stress disorder Ann N Y Acad Sci 1997 821 444 8 9238226
  35. [43]Kokacya MH Increased mean platelet volume in patients with panic disorder Neuropsychiatr Dis Treat 2015 11 2629 26508858 PMC4610766
  36. [44]Canan F Association of mean platelet volume with DSM-IV major depression in a large community-based population: The MELEN study J Psychiatr Res 2012 46 298 302 22154758
  37. [45]Wang M Effect of cyclooxygenase‑2 inhibition on the development of post‑traumatic stress disorder in rats Mol Med Rep 2018 17 4925 32 29393449 PMC5865951
  38. [46]Lerer B Bleich A Bennett ER Ebstein RP Balkin J Platelet adenylate cyclase and phospholipase C activity in posttraumatic stress disorder Biol Psychiatry 1990 27 735 40 2328269
  39. [47]Pole N Effects of gender and ethnicity on duty-related posttraumatic stress symptoms among urban police officers J Nerv Ment Dis 2001 189 442 8 11504321
  40. [48]Marshall GN Schell TL Miles JNV Ethnic differences in posttraumatic distress: hispanics’ symptoms differ in kind and degree J Consult Clin Psychol 2009 77 1169 78 19968392 PMC2821595
  41. [49]Blessing EM Biological predictors of insulin resistance associated with posttraumatic stress disorder in young military veterans Psychoneuroendocrinology 2017 82 91 7 28521179
  42. [50]Piubelli C MicroRNAs and cardiac cell fate Cells 2014 3 802 23 25100020 PMC4197636
  43. [51]Liu N microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart Genes Dev 2008 22 3242 54 19015276 PMC2600761
  44. [52]Angelini A Li Z Mericskay M Decaux J-F Regulation of connective tissue growth factor and cardiac fibrosis by an SRF/MicroRNA-133a axis PLoS ONE 2015 10 e0139858 26440278 PMC4595333
  45. [53]Wang K Long B Zhou J Li P F. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy J Biol Chem 2010 285 11903 12 20177053 PMC2852927
  46. [54]Emanueli C, et al. Coronary artery-bypass-graft surgery increases the plasma concentration of exosomes carrying a cargo of cardiac microRNAs: an example of exosome trafficking out of the human heart with potential for cardiac biomarker discovery. PLoS ONE. 2016;11:e0154274. PMC4851293 27128471
  47. [55]Hoge CW Riviere LA Wilk JE Herrell RK Weathers FW The prevalence of post-traumatic stress disorder (PTSD) in US combat soldiers: a head-to-head comparison of DSM-5 versus DSM-IV-TR symptom criteria with the PTSD checklist Lancet Psychiatry 2014 1 269 77 26360860
  48. [56]Shalev AY Prospective study of posttraumatic stress disorder and depression following trauma Am J Psychiatry 1998 155 630 7 9585714
  49. [58]Brown PJ Wolfe J Substance abuse and post-traumatic stress disorder comorbidity Drug Alcohol Depend 1994 35 51 9 8082556
  50. [59]Cohen BE Posttraumatic stress disorder and health-related quality of life in patients with coronary heart disease Arch Gen Psychiatry 2009 66 1214 19884609 PMC2822711
  51. [60]Boyko EJ Risk of diabetes in US military service members in relation to combat deployment and mental health Diabetes Care 2010 33 1771 7 20484134 PMC2909060
  52. [61]Chowbina S, et al. SysBioCube: A data warehouse and integrative data analysis platform facilitating systems biology studies of disorders of military relevance. AMIA Summits Transl Sci Proc. 2013:34–8. PMC3814498 24303294

Cited by

Sorted by citations

Authors
The PTSD Systems Biology Consortium, Dean, K. R., Hammamieh, R., Mellon, S. H., Abu-Amara, D., Flory, J. D., Guffanti, G., Wang, K., Daigle, B. J., Gautam, A., Lee, I., Yang, R., Almli, L. M., Bersani, F. S., Chakraborty, N., Donohue, D., Kerley, K., Kim, T.-K., Laska, E., Young Lee, M., Lindqvist, D., Lori, A., Lu, L., Misganaw, B., Muhie, S., Newman, J., Price, N. D., Qin, S., Reus, V. I., Siegel, C., Somvanshi, P. R., Thakur, G. S., Zhou, Y., Hood, L., Ressler, K. J., Wolkowitz, O. M., Yehuda, R., Jett, M., Doyle, F. J., & Marmar, C.
Affiliations
  • Harvard University (US)
  • United States Army Medical Research and Development Command (US)
  • University of California, San Francisco (US)
  • James J. Peters VA Medical Center (US)
  • McLean Hospital (US)
  • Institute for Systems Biology (US)
  • University of Memphis (US)
  • Frederick National Laboratory for Cancer Research (US)
  • Emory University (US)
  • The Geneva Foundation (US)
Corresponding author
Doyle, Francis J.
Venue
Molecular Psychiatry
Published
2019-09-10
Volume
25
Issue
12
Pages
3337-3349
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2972380287
Cited by
101
References
6
Citations by year
2026: 10 · 2025: 7 · 2024: 16 · 2023: 13 · 2022: 18 · 2021: 12 · 2020: 23 · 2019: 2
FWCI
16.06
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • eScholarship (California Digital Library) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
United States Department of Defense | United States Army | U.S. Army Research, Development and Engineering Command | Army Research Office (W911NF-13-1-0376, W911NF-17-2-0086, W911NF-18-2-0056, W911NF-17-1-0069)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
  • Social Sciences › Psychology › Clinical Psychology › Child Abuse and Trauma
Keywords
post-traumatic stress disorder, combat-related PTSD, diagnostic biomarkers, multi-omics integration, veterans, biomarker panel, polygenic risk, recursive feature elimination, support vector machine, diagnostic accuracy, military personnel
MeSH terms
Brain, Humans, Male, Military Personnel, Stress Disorders, Post-Traumatic, Veterans, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review